scispace - formally typeset
Open AccessJournal ArticleDOI

Acute Myocardial Infarction and Myocarditis following COVID-19 Vaccination.

TLDR
A pooled analysis of patients presenting with cardiac manifestations following COVID-19 vaccination highlights the differences between myocarditis and acute myocardial infarction (AMI) presentations in temporal association with the vaccination as mentioned in this paper.
Abstract
Background Emerging reports raise concerns on the potential association between the COVID-19 vaccines and cardiac manifestations. We sought to evaluate cardiac complications associated with COVID-19 vaccination in a pooled analysis from our institution's cohort study and systematic review. Methods Consecutive patients admitted in a tertiary hospital in Singapore between 1 January 2021 and 31 March 2021, with onset of cardiac manifestations within 14 days following COVID-19 vaccination were studied. Furthermore, a systematic review was performed, with PubMed, Embase, Research Square, MedRxiv, and LitCovid databases accessed from inception up to 29 June 2021. Relevant manuscripts reporting individual patient data on cardiac complications following COVID-19 vaccination were included. Results Thirty patients were included in the study cohort, with 29 diagnosed with acute myocardial infarction (AMI) and 1 with myocarditis. Five patients developed heart failure, two had cardiogenic shock, three intubated, and one had cardiovascular-related mortality. In the systematic review, 16 studies were included with 41 myocarditis and six AMI cases. In the pooled analysis of the study cohort and the systematic review, 35 patients had AMI and 42 had myocarditis. Majority were men, and myocarditis patients were younger than AMI patients. Myocarditis patients tended to present 72 hours post-vaccination, while AMI patients were older and typically presented 24 hours post-vaccination. Majority with AMI or myocarditis developed symptoms after the first and second vaccination dose respectively. Conclusions This pooled analysis of patients presenting with cardiac manifestations following COVID-19 vaccination highlights the differences between myocarditis and AMI presentations in temporal association with the vaccination.

read more

Citations
More filters
Journal ArticleDOI

Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies

TL;DR: In this article , a review of biomarkers associated with endothelial cell activation in COVID-19 and mechanistic insights into the molecular basis of endothelial activation/dysfunction in macro-and micro-vasculature of CoV-19 patients are provided.
Journal ArticleDOI

What Should We Do after the COVID-19 Vaccination? Vaccine-Associated Diseases and Precautionary Measures against Adverse Reactions

TL;DR: A few recommendations to prevent vaccine-associated disease are provided, including high-intensity exercise, alcohol, tobacco smoking, and baths promote inflammatory cytokines, which may exacerbate the adverse reactions after vaccination.
Journal ArticleDOI

Profiling COVID-19 Vaccine Adverse Events by Statistical and Ontological Analysis of VAERS Case Reports

TL;DR: Notably, severe COVID-19 vaccine AEs (including myocarditis, GBS, and TTS) rarely occur in comparison to the large number of COvid-19 vaccinations administered in the United States, affirming the overall safety of these CO VID-19 vaccines.
Journal ArticleDOI

Signaling COVID-19 Vaccine Adverse Events

TL;DR: In this article , the authors investigate the problem of masking in the context of COVID-19 vaccine signal detection, assessing its impact, extent, and root causes, based on data underlying the Vaccine Adverse Event Reporting System, three commonly applied statistical signal detection methodologies, and a more advanced regression-based methodology.
References
More filters
Journal ArticleDOI

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.

TL;DR: In this article, the authors reported several cases of unusual thrombotic events and thrombo-cellocytopenia after vaccination with the recombinant adenoviral vector encoding the spike protein antigen of spike proteins.
Journal ArticleDOI

Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction

TL;DR: In this review, the concept of molecular mimicry and its application in explaining post vaccination autoimmune phenomena is addressed and the principal examples of the influenza, hepatitis B, and human papilloma virus vaccines, all suspected to induce autoimmunity via Molecular mimicry are reviewed.
Journal ArticleDOI

Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots.

Jacqui Wise
- 11 Mar 2021 - 
TL;DR: Denmark has temporarily suspended use of the Oxford-AstraZeneca covid-19 vaccine as a precautionary move after reports of blood clots and one death.